Human Beta Cell Regenerative Drug Therapy for Diabetes: Past Achievements and Future Challenges

Human Beta Cell Regenerative Drug Therapy for Diabetes: Past Achievements and Future Challenges

A quantitative deficiency of normally functioning insulin-producing pancreatic beta cells is a major contributor to all common forms of diabetes. This is the underlying premise for attempts to replace beta cells in people with diabetes by pancreas transplantation, pancreatic islet transplantation, a...

Full description

Bibliographic Details
Main Authors: Peng Wang, Esra Karakose, Lauryn Choleva, Kunal Kumar, Robert J. DeVita, Adolfo Garcia-Ocaña, Andrew F. Stewart
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Endocrinology
Subjects:
human
diabetes
beta cell
insulin
regeneration
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2021.671946/full

Similar Items

Similar Items